Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma
- PMID: 36548282
- PMCID: PMC9778931
- DOI: 10.1371/journal.pone.0279290
Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma
Abstract
Objective: This study examined the reliability and validity of a Shame and Stigma Scale (SSS) and assessed shame and stigma among patients with facial disfigurement from nasopharyngeal carcinoma (NPC).
Methods: Data were collected from 218 patients with NPC through a cross-sectional survey between January 14, 2020, and December 1, 2020. The original SSS is a 20-item scale with four dimensions (i.e., shame with appearance, sense of stigma, regret, and social/speech concern). We used Cronbach's alpha and McDonald's omega to assess reliability and exploratory factor analysis (EFA) to assess the factor structure. We also used Pearson correlation analysis to examine the relationship between each item and total score of scale items and convergent validity.
Results: The final 18-item SSS had a Cronbach's alpha coefficient of .89. The EFA revealed that the SSS has a four-factor structure: sense of stigma, social/speech concern, shame with appearance, and regret. These factors showed satisfactory reliability, with McDonald's omega coefficients of .87, .77, .86, and .79, respectively. The scale showed significant relationship between each item and total score of scale items with respect to item-total correlations, item-subscale correlations, and item-other-subscale correlations. Convergent validity was supported by the significant positively correlated with the total scores for depression and anxiety.
Conclusion: The SSS is valid and reliable in assessing shame and stigma and monitoring treatment compliance among patients with NPC.
Copyright: © 2022 Cai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Preliminary evaluation of the reliability and validity of the Shame and Stigma Scale in head and neck cancer.Head Neck. 2013 Feb;35(2):172-83. doi: 10.1002/hed.22943. Epub 2012 Feb 24. Head Neck. 2013. PMID: 22368160
-
Validation of the Malay Version of the Shame and Stigma Scale among Cancer Patients in Malaysia.Int J Environ Res Public Health. 2022 Nov 1;19(21):14266. doi: 10.3390/ijerph192114266. Int J Environ Res Public Health. 2022. PMID: 36361144 Free PMC article.
-
Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer.Cancer Manag Res. 2019 Dec 9;11:10297-10305. doi: 10.2147/CMAR.S228843. eCollection 2019. Cancer Manag Res. 2019. PMID: 31849519 Free PMC article.
-
Development and Validation of the COVID-19-Related Stigma Scale for Healthcare Workers (CSS-HCWs).Int J Environ Res Public Health. 2022 Aug 5;19(15):9641. doi: 10.3390/ijerph19159641. Int J Environ Res Public Health. 2022. PMID: 35954996 Free PMC article. Review.
-
Psychometric development and evaluation of a COVID-19 social stigma scale in Indonesia.PLoS One. 2023 Apr 5;18(4):e0283870. doi: 10.1371/journal.pone.0283870. eCollection 2023. PLoS One. 2023. PMID: 37018328 Free PMC article. Review.
Cited by
-
Factors associated with shame and stigma among head and neck cancer patients: a cross-sectional study.Support Care Cancer. 2024 May 15;32(6):357. doi: 10.1007/s00520-024-08568-2. Support Care Cancer. 2024. PMID: 38750287
-
The role of illness-related cognition in the relationships between resilience and depression/anxiety in nasopharyngeal cancer patients.Cancer Med. 2023 Dec;12(23):21408-21418. doi: 10.1002/cam4.6688. Epub 2023 Nov 22. Cancer Med. 2023. PMID: 37991167 Free PMC article.
-
Validation of the Canadian Version of the Shame and Stigma Scale for Head and Neck Cancer Patients.Curr Oncol. 2023 Aug 11;30(8):7553-7565. doi: 10.3390/curroncol30080548. Curr Oncol. 2023. PMID: 37623029 Free PMC article.
References
-
- WHO. Depression and Other Common Mental Disorders: Global Health Estimates 2017. Available from: https://www.who.int/publications/i/item/depression-global-health-estimates.
-
- McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al.. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. International journal of radiation oncology, biology, physics. 2018;102(2):340–52. doi: 10.1016/j.ijrobp.2018.05.060 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources